APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

In-vitro Toxicity Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global In-vitro Toxicity Testing Market Analysis and Forecast 2026-2032

Report ID 174002300222 December 2025191 pages

Choose your research edition.

Industry ResearchIn-vitro Toxicity Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal In-vitro Toxicity Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal In-vitro Toxicity Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-vitro Toxicity Testing Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal In-vitro Toxicity Testing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global In-vitro Toxicity Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for In-vitro Toxicity Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for In-vitro Toxicity Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for In-vitro Toxicity Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for In-vitro Toxicity Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of In-vitro Toxicity Testing include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., General Electric Co., Evotec AG, Eurofins GSC Lux Sarl, Charles River Laboratories International Inc., CELTHER POLSKA Sp z o.o. and Bio-Rad Laboratories Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for In-vitro Toxicity Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of In-vitro Toxicity Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for In-vitro Toxicity Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the In-vitro Toxicity Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global In-vitro Toxicity Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for In-vitro Toxicity Testing revenue, projected growth trends, production technology, application and end-user industry.

In-vitro Toxicity Testing Segment by Company

Thermo Fisher Scientific Inc.

Merck KGaA

Agilent Technologies Inc.

General Electric Co.

Evotec AG

Eurofins GSC Lux Sarl

Charles River Laboratories International Inc.

CELTHER POLSKA Sp z o.o.

Bio-Rad Laboratories Inc.

Abbott Laboratories

In-vitro Toxicity Testing Segment by Type

Static Well Plate System

Multi-compartmental Perfused Systems

In-vitro Toxicity Testing Segment by Application

Pharmaceutical and Biotechnology Companies

Academic and Research Institutions

Others

In-vitro Toxicity Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-vitro Toxicity Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-vitro Toxicity Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-vitro Toxicity Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of In-vitro Toxicity Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of In-vitro Toxicity Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-vitro Toxicity Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In-vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Static Well Plate System Major Player Table 3. Multi-compartmental Perfused Systems Major Player Table 4. Global In-vitro Toxicity Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical and Biotechnology Companies Major Player Table 6. Academic and Research Institutions Major Player Table 7. Others Major Player Table 8. In-vitro Toxicity Testing Industry Trends Table 9. In-vitro Toxicity Testing Industry Drivers Table 10. In-vitro Toxicity Testing Industry Opportunities and Challenges Table 11. In-vitro Toxicity Testing Industry Restraints Table 12. Global In-vitro Toxicity Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global In-vitro Toxicity Testing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global In-vitro Toxicity Testing Market Share by Region (2021-2026) Table 15. Global In-vitro Toxicity Testing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global In-vitro Toxicity Testing Market Share by Region (2027-2032) Table 17. Global In-vitro Toxicity Testing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global In-vitro Toxicity Testing Revenue Market Share by Players (2021-2026) Table 19. Global In-vitro Toxicity Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global In-vitro Toxicity Testing Key Players Headquarters & Area Served Table 21. Global In-vitro Toxicity Testing Players, Product Type & Application Table 22. Global In-vitro Toxicity Testing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global In-vitro Toxicity Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global In-vitro Toxicity Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global In-vitro Toxicity Testing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global In-vitro Toxicity Testing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global In-vitro Toxicity Testing Revenue Market Share by Type (2021-2026) Table 29. Global In-vitro Toxicity Testing Revenue Market Share by Type (2027-2032) Table 30. Global In-vitro Toxicity Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global In-vitro Toxicity Testing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global In-vitro Toxicity Testing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global In-vitro Toxicity Testing Revenue Market Share by Application (2021-2026) Table 34. Global In-vitro Toxicity Testing Revenue Market Share by Application (2027-2032) Table 35. Thermo Fisher Scientific Inc. Company Information Table 36. Thermo Fisher Scientific Inc. Business Overview Table 37. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Portfolio Table 39. Thermo Fisher Scientific Inc. Recent Development Table 40. Merck KGaA Company Information Table 41. Merck KGaA Business Overview Table 42. Merck KGaA In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck KGaA In-vitro Toxicity Testing Product Portfolio Table 44. Merck KGaA Recent Development Table 45. Agilent Technologies Inc. Company Information Table 46. Agilent Technologies Inc. Business Overview Table 47. Agilent Technologies Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Agilent Technologies Inc. In-vitro Toxicity Testing Product Portfolio Table 49. Agilent Technologies Inc. Recent Development Table 50. General Electric Co. Company Information Table 51. General Electric Co. Business Overview Table 52. General Electric Co. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. General Electric Co. In-vitro Toxicity Testing Product Portfolio Table 54. General Electric Co. Recent Development Table 55. Evotec AG Company Information Table 56. Evotec AG Business Overview Table 57. Evotec AG In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Evotec AG In-vitro Toxicity Testing Product Portfolio Table 59. Evotec AG Recent Development Table 60. Eurofins GSC Lux Sarl Company Information Table 61. Eurofins GSC Lux Sarl Business Overview Table 62. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Portfolio Table 64. Eurofins GSC Lux Sarl Recent Development Table 65. Charles River Laboratories International Inc. Company Information Table 66. Charles River Laboratories International Inc. Business Overview Table 67. Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Portfolio Table 69. Charles River Laboratories International Inc. Recent Development Table 70. CELTHER POLSKA Sp z o.o. Company Information Table 71. CELTHER POLSKA Sp z o.o. Business Overview Table 72. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Portfolio Table 74. CELTHER POLSKA Sp z o.o. Recent Development Table 75. Bio-Rad Laboratories Inc. Company Information Table 76. Bio-Rad Laboratories Inc. Business Overview Table 77. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Portfolio Table 79. Bio-Rad Laboratories Inc. Recent Development Table 80. Abbott Laboratories Company Information Table 81. Abbott Laboratories Business Overview Table 82. Abbott Laboratories In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Abbott Laboratories In-vitro Toxicity Testing Product Portfolio Table 84. Abbott Laboratories Recent Development Table 85. North America In-vitro Toxicity Testing Revenue by Type (2021-2026) & (US$ Million) Table 86. North America In-vitro Toxicity Testing Revenue by Type (2027-2032) & (US$ Million) Table 87. North America In-vitro Toxicity Testing Revenue by Application (2021-2026) & (US$ Million) Table 88. North America In-vitro Toxicity Testing Revenue by Application (2027-2032) & (US$ Million) Table 89. North America In-vitro Toxicity Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America In-vitro Toxicity Testing Revenue by Country (2021-2026) & (US$ Million) Table 91. North America In-vitro Toxicity Testing Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe In-vitro Toxicity Testing Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe In-vitro Toxicity Testing Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe In-vitro Toxicity Testing Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe In-vitro Toxicity Testing Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe In-vitro Toxicity Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe In-vitro Toxicity Testing Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe In-vitro Toxicity Testing Revenue by Country (US$ Million) & (2027-2032) Table 99. China In-vitro Toxicity Testing Revenue by Type (2021-2026) & (US$ Million) Table 100. China In-vitro Toxicity Testing Revenue by Type (2027-2032) & (US$ Million) Table 101. China In-vitro Toxicity Testing Revenue by Application (2021-2026) & (US$ Million) Table 102. China In-vitro Toxicity Testing Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia In-vitro Toxicity Testing Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia In-vitro Toxicity Testing Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia In-vitro Toxicity Testing Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia In-vitro Toxicity Testing Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia In-vitro Toxicity Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia In-vitro Toxicity Testing Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia In-vitro Toxicity Testing Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA In-vitro Toxicity Testing Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA In-vitro Toxicity Testing Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA In-vitro Toxicity Testing Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA In-vitro Toxicity Testing Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA In-vitro Toxicity Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA In-vitro Toxicity Testing Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA In-vitro Toxicity Testing Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. In-vitro Toxicity Testing Image Figure 2. Global In-vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In-vitro Toxicity Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Static Well Plate System Image Figure 5. Multi-compartmental Perfused Systems Image Figure 6. Global In-vitro Toxicity Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global In-vitro Toxicity Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical and Biotechnology Companies Image Figure 9. Academic and Research Institutions Image Figure 10. Others Image Figure 11. Global In-vitro Toxicity Testing Market Size (US$ Million) & (2021-2032) Figure 12. Global In-vitro Toxicity Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global In-vitro Toxicity Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global In-vitro Toxicity Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global In-vitro Toxicity Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global In-vitro Toxicity Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global In-vitro Toxicity Testing Revenue Market Share by Type (2021-2032) Figure 19. Global In-vitro Toxicity Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global In-vitro Toxicity Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global In-vitro Toxicity Testing Revenue Market Share by Application (2021-2032) Figure 22. North America In-vitro Toxicity Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America In-vitro Toxicity Testing Revenue Share by Type (2021-2032) Figure 24. North America In-vitro Toxicity Testing Revenue Share by Application (2021-2032) Figure 25. North America In-vitro Toxicity Testing Revenue Share by Country (2021-2032) Figure 26. United States In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe In-vitro Toxicity Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe In-vitro Toxicity Testing Revenue Share by Type (2021-2032) Figure 31. Europe In-vitro Toxicity Testing Revenue Share by Application (2021-2032) Figure 32. Europe In-vitro Toxicity Testing Revenue Share by Country (2021-2032) Figure 33. Germany In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China In-vitro Toxicity Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China In-vitro Toxicity Testing Revenue Share by Type (2021-2032) Figure 43. China In-vitro Toxicity Testing Revenue Share by Application (2021-2032) Figure 44. Asia In-vitro Toxicity Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia In-vitro Toxicity Testing Revenue Share by Type (2021-2032) Figure 46. Asia In-vitro Toxicity Testing Revenue Share by Application (2021-2032) Figure 47. Asia In-vitro Toxicity Testing Revenue Share by Region (2021-2032) Figure 48. Japan In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA In-vitro Toxicity Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA In-vitro Toxicity Testing Revenue Share by Type (2021-2032) Figure 56. SAMEA In-vitro Toxicity Testing Revenue Share by Application (2021-2032) Figure 57. SAMEA In-vitro Toxicity Testing Revenue Share by Country (2021-2032) Figure 58. Brazil In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt In-vitro Toxicity Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Static Well Plate System
  • Multi-compartmental Perfused Systems
Applications
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Others
Companies covered
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies Inc.
  • General Electric Co.
  • Evotec AG
  • Eurofins GSC Lux Sarl
  • Charles River Laboratories International Inc.
  • CELTHER POLSKA Sp z o.o.
  • Bio-Rad Laboratories Inc.
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 In-vitro Toxicity Testing Market by Type
  3. 1.2.1 Global In-vitro Toxicity Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Static Well Plate System
  5. 1.2.3 Multi-compartmental Perfused Systems
  6. 1.3 In-vitro Toxicity Testing Market by Application
  7. 1.3.1 Global In-vitro Toxicity Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical and Biotechnology Companies
  9. 1.3.3 Academic and Research Institutions
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 In-vitro Toxicity Testing Market Dynamics
  1. 2.1 In-vitro Toxicity Testing Industry Trends
  2. 2.2 In-vitro Toxicity Testing Industry Drivers
  3. 2.3 In-vitro Toxicity Testing Industry Opportunities and Challenges
  4. 2.4 In-vitro Toxicity Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global In-vitro Toxicity Testing Market Perspective (2021-2032)
  2. 3.2 Global In-vitro Toxicity Testing Growth Trends by Region
  3. 3.2.1 Global In-vitro Toxicity Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global In-vitro Toxicity Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global In-vitro Toxicity Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global In-vitro Toxicity Testing Revenue by Players
  2. 4.1.1 Global In-vitro Toxicity Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global In-vitro Toxicity Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global In-vitro Toxicity Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global In-vitro Toxicity Testing Key Players Headquarters & Area Served
  7. 4.4 Global In-vitro Toxicity Testing Players, Product Type & Application
  8. 4.5 Global In-vitro Toxicity Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global In-vitro Toxicity Testing Market CR5 and HHI
  11. 4.6.3 2025 In-vitro Toxicity Testing Tier 1, Tier 2, and Tier 3
5 In-vitro Toxicity Testing Market Size by Type
  1. 5.1 Global In-vitro Toxicity Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global In-vitro Toxicity Testing Revenue by Type (2021-2032)
  3. 5.3 Global In-vitro Toxicity Testing Revenue Market Share by Type (2021-2032)
6 In-vitro Toxicity Testing Market Size by Application
  1. 6.1 Global In-vitro Toxicity Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global In-vitro Toxicity Testing Revenue by Application (2021-2032)
  3. 6.3 Global In-vitro Toxicity Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific Inc.
  2. 7.1.1 Thermo Fisher Scientific Inc. Company Information
  3. 7.1.2 Thermo Fisher Scientific Inc. Business Overview
  4. 7.1.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Inc. Recent Developments
  7. 7.2 Merck KGaA
  8. 7.2.1 Merck KGaA Company Information
  9. 7.2.2 Merck KGaA Business Overview
  10. 7.2.3 Merck KGaA In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck KGaA In-vitro Toxicity Testing Product Portfolio
  12. 7.2.5 Merck KGaA Recent Developments
  13. 7.3 Agilent Technologies Inc.
  14. 7.3.1 Agilent Technologies Inc. Company Information
  15. 7.3.2 Agilent Technologies Inc. Business Overview
  16. 7.3.3 Agilent Technologies Inc. In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent Technologies Inc. In-vitro Toxicity Testing Product Portfolio
  18. 7.3.5 Agilent Technologies Inc. Recent Developments
  19. 7.4 General Electric Co.
  20. 7.4.1 General Electric Co. Company Information
  21. 7.4.2 General Electric Co. Business Overview
  22. 7.4.3 General Electric Co. In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 General Electric Co. In-vitro Toxicity Testing Product Portfolio
  24. 7.4.5 General Electric Co. Recent Developments
  25. 7.5 Evotec AG
  26. 7.5.1 Evotec AG Company Information
  27. 7.5.2 Evotec AG Business Overview
  28. 7.5.3 Evotec AG In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Evotec AG In-vitro Toxicity Testing Product Portfolio
  30. 7.5.5 Evotec AG Recent Developments
  31. 7.6 Eurofins GSC Lux Sarl
  32. 7.6.1 Eurofins GSC Lux Sarl Company Information
  33. 7.6.2 Eurofins GSC Lux Sarl Business Overview
  34. 7.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Portfolio
  36. 7.6.5 Eurofins GSC Lux Sarl Recent Developments
  37. 7.7 Charles River Laboratories International Inc.
  38. 7.7.1 Charles River Laboratories International Inc. Company Information
  39. 7.7.2 Charles River Laboratories International Inc. Business Overview
  40. 7.7.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Portfolio
  42. 7.7.5 Charles River Laboratories International Inc. Recent Developments
  43. 7.8 CELTHER POLSKA Sp z o.o.
  44. 7.8.1 CELTHER POLSKA Sp z o.o. Company Information
  45. 7.8.2 CELTHER POLSKA Sp z o.o. Business Overview
  46. 7.8.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Portfolio
  48. 7.8.5 CELTHER POLSKA Sp z o.o. Recent Developments
  49. 7.9 Bio-Rad Laboratories Inc.
  50. 7.9.1 Bio-Rad Laboratories Inc. Company Information
  51. 7.9.2 Bio-Rad Laboratories Inc. Business Overview
  52. 7.9.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Portfolio
  54. 7.9.5 Bio-Rad Laboratories Inc. Recent Developments
  55. 7.10 Abbott Laboratories
  56. 7.10.1 Abbott Laboratories Company Information
  57. 7.10.2 Abbott Laboratories Business Overview
  58. 7.10.3 Abbott Laboratories In-vitro Toxicity Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Abbott Laboratories In-vitro Toxicity Testing Product Portfolio
  60. 7.10.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America In-vitro Toxicity Testing Revenue (2021-2032)
  2. 8.2 North America In-vitro Toxicity Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America In-vitro Toxicity Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America In-vitro Toxicity Testing Revenue by Type (2027-2032)
  5. 8.3 North America In-vitro Toxicity Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America In-vitro Toxicity Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America In-vitro Toxicity Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America In-vitro Toxicity Testing Revenue by Application (2027-2032)
  9. 8.5 North America In-vitro Toxicity Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America In-vitro Toxicity Testing Revenue by Country
  11. 8.6.1 North America In-vitro Toxicity Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America In-vitro Toxicity Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America In-vitro Toxicity Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe In-vitro Toxicity Testing Revenue (2021-2032)
  2. 9.2 Europe In-vitro Toxicity Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe In-vitro Toxicity Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe In-vitro Toxicity Testing Revenue by Type (2027-2032)
  5. 9.3 Europe In-vitro Toxicity Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe In-vitro Toxicity Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe In-vitro Toxicity Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe In-vitro Toxicity Testing Revenue by Application (2027-2032)
  9. 9.5 Europe In-vitro Toxicity Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe In-vitro Toxicity Testing Revenue by Country
  11. 9.6.1 Europe In-vitro Toxicity Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe In-vitro Toxicity Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe In-vitro Toxicity Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China In-vitro Toxicity Testing Revenue (2021-2032)
  2. 10.2 China In-vitro Toxicity Testing Revenue by Type (2021-2032)
  3. 10.2.1 China In-vitro Toxicity Testing Revenue by Type (2021-2026)
  4. 10.2.2 China In-vitro Toxicity Testing Revenue by Type (2027-2032)
  5. 10.3 China In-vitro Toxicity Testing Revenue Share by Type (2021-2032)
  6. 10.4 China In-vitro Toxicity Testing Revenue by Application (2021-2032)
  7. 10.4.1 China In-vitro Toxicity Testing Revenue by Application (2021-2026)
  8. 10.4.2 China In-vitro Toxicity Testing Revenue by Application (2027-2032)
  9. 10.5 China In-vitro Toxicity Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia In-vitro Toxicity Testing Revenue (2021-2032)
  2. 11.2 Asia In-vitro Toxicity Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia In-vitro Toxicity Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia In-vitro Toxicity Testing Revenue by Type (2027-2032)
  5. 11.3 Asia In-vitro Toxicity Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia In-vitro Toxicity Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia In-vitro Toxicity Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia In-vitro Toxicity Testing Revenue by Application (2027-2032)
  9. 11.5 Asia In-vitro Toxicity Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia In-vitro Toxicity Testing Revenue by Country
  11. 11.6.1 Asia In-vitro Toxicity Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia In-vitro Toxicity Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia In-vitro Toxicity Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA In-vitro Toxicity Testing Revenue (2021-2032)
  2. 12.2 SAMEA In-vitro Toxicity Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA In-vitro Toxicity Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA In-vitro Toxicity Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA In-vitro Toxicity Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA In-vitro Toxicity Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA In-vitro Toxicity Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA In-vitro Toxicity Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA In-vitro Toxicity Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA In-vitro Toxicity Testing Revenue by Country
  11. 12.6.1 SAMEA In-vitro Toxicity Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA In-vitro Toxicity Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA In-vitro Toxicity Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst